Christoph Hammerstingl Selected Research

Intracranial Embolism

12/2013	Cognitive trajectory after transcatheter aortic valve implantation.
5/2006	Atrial thrombi-a prospective follow-up study over 3 years with transesophageal echocardiography and cranial magnetic resonance imaging.
6/2005	Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging.
9/2004	Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christoph Hammerstingl Research Topics

Disease

8	Atrial Fibrillation 01/2018 - 08/2003
7	Thrombosis (Thrombus) 01/2021 - 10/2007
7	Aortic Valve Stenosis (Aortic Stenosis) 10/2020 - 08/2012
6	Hemorrhage 03/2019 - 09/2003
6	Stroke (Strokes) 01/2018 - 04/2010
5	Aortic Valve Insufficiency (Aortic Regurgitation) 04/2016 - 03/2012
4	Intracranial Embolism 12/2013 - 09/2004
3	Inflammation (Inflammations) 01/2018 - 06/2012
3	Coronary Artery Disease (Coronary Atherosclerosis) 07/2017 - 04/2016
3	Heart Failure 12/2016 - 03/2016
3	Thrombocytopenia (Thrombopenia) 10/2016 - 10/2007
3	Mitral Valve Insufficiency (Mitral Regurgitation) 10/2016 - 01/2016
3	Renal Insufficiency (Renal Failure) 09/2011 - 10/2007
2	Atrial Heart Septal Defects (Atrial Septal Defect) 07/2018 - 08/2015
2	Coronary Stenosis (Coronary Artery Stenosis) 07/2017 - 10/2016
2	Atrial Flutter (Flutter, Atrial) 08/2016 - 04/2015
2	Pulmonary Arterial Hypertension 07/2016 - 01/2013
2	Sarcoidosis (Schaumann Disease) 01/2016 - 01/2013
2	Chronic Obstructive Pulmonary Disease (COPD) 01/2016 - 01/2016
2	Rupture 12/2015 - 04/2012
2	Pulmonary Hypertension 08/2014 - 01/2014
2	Acute Kidney Injury (Acute Renal Failure) 03/2014 - 11/2010
2	Thromboembolism 09/2011 - 09/2003
2	Body Weight (Weight, Body) 02/2009 - 10/2007
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2019
1	Acute-On-Chronic Liver Failure 03/2019
1	Fibrosis (Cirrhosis) 01/2018
1	Ischemia 07/2017
1	Atherosclerosis 03/2017
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 12/2016
1	Vascular System Injuries 01/2016
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2016
1	Diabetes Mellitus 01/2016
1	Bundle-Branch Block (Fascicular Block) 05/2015
1	Neoplasm Metastasis (Metastasis) 01/2015
1	Neoplasms (Cancer) 01/2015
1	Emphysema 01/2015
1	Embolic Stroke 07/2014
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2013
1	Cognitive Dysfunction 12/2013
1	Mitral Valve Stenosis (Mitral Stenosis) 09/2013
1	Obstructive Sleep Apnea 01/2013
1	Myocardial Infarction 07/2012
1	Embolism (Embolus) 07/2012
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 06/2012
1	Chronic Renal Insufficiency 01/2012
1	Dyspnea (Shortness of Breath) 01/2012
1	Heart Diseases (Heart Disease) 12/2011

Drug/Important Bio-Agent (IBA)

7	AnticoagulantsIBA 01/2021 - 10/2007
5	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 07/2012 - 05/2007
4	RivaroxabanIBA 01/2018 - 04/2013
4	Enoxaparin (Lovenox)FDA LinkGeneric 06/2009 - 08/2003
3	Biomarkers (Surrogate Marker)IBA 01/2018 - 10/2015
3	Brain Natriuretic Peptide (Natrecor)FDA Link 03/2016 - 10/2015
3	Phosphopyruvate Hydratase (Enolase)IBA 03/2013 - 04/2010
3	Heparin (Liquaemin)FDA LinkGeneric 09/2011 - 10/2007
2	von Willebrand FactorIBA 01/2018 - 03/2017
2	C-Reactive ProteinIBA 01/2018 - 10/2015
2	Thrombin FDA Link 01/2018 - 10/2016
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 10/2015
2	Vitamin K FDA Link 01/2018 - 08/2016
2	Dobutamine FDA LinkGeneric 07/2017 - 10/2016
2	CreatinineIBA 03/2014 - 06/2009
2	Phenprocoumon (Liquamar)FDA Link 02/2009 - 08/2003
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	Coloring Agents (Dyes)IBA 03/2019
1	Contrast MediaIBA 03/2019
1	AntithrombinsIBA 01/2018
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2018
1	Prothrombin (Factor II)IBA 01/2018
1	fibrin fragment D (D-dimer)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 07/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2017
1	AntigensIBA 03/2017
1	Clopidogrel (Plavix)FDA Link 01/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2016
1	macitentanIBA 07/2016
1	GadoliniumIBA 01/2016
1	TroponinIBA 01/2016
1	Interleukin-8 (Interleukin 8)IBA 10/2015
1	Hemoglobins (Hemoglobin)IBA 08/2014
1	DEAE-Dextran (Pulsar)IBA 01/2013
1	Retinaldehyde (Retinal)IBA 07/2012

Therapy/Procedure

20	Therapeutics 01/2021 - 09/2003
17	Transcatheter Aortic Valve Replacement 10/2020 - 11/2010
6	Prostheses and Implants (Prosthesis) 04/2016 - 03/2012
3	Catheters 01/2016 - 04/2012
2	Percutaneous Coronary Intervention 01/2016 - 01/2015
2	Stents 01/2016 - 05/2015
2	Electric Countershock (Cardioversion) 04/2015 - 06/2005
1	Surgical Portasystemic Shunt (Portosystemic Shunt) 03/2019
1	Punctures 07/2018
1	Liver Transplantation 01/2018
1	Heart Transplantation (Grafting, Heart) 12/2016
1	Mitral Valve Annuloplasty 10/2016
1	Patient Readmission 10/2015
1	Drug Therapy (Chemotherapy) 01/2015
1	Pneumonectomy (Lung Volume Reduction) 01/2015
1	Embolic Protection Devices 12/2013
1	Renal Dialysis (Hemodialysis) 01/2012